N. Løkken

发表

European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

E. Mercuri, E. Malfatti, R. Carlier, 2019, Journal of Neurology.

No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross‐over trial

P. Laforêt, J. Vissing, N. Voermans, 2022, Journal of inherited metabolic disease.

Muscle contractility of leg muscles in patients with mitochondrial myopathies.

J. Vissing, J. Dahlqvist, G. Hedermann, 2019, Mitochondrion.

Axial muscle involvement in patients with limb girdle muscular dystrophy type R9

J. Vissing, N. Witting, J. Dahlqvist, 2022, Muscle & nerve.

Impaired lipolysis in propionic acidemia: A new metabolic myopathy?

J. Vissing, G. van Hall, A. Lund, 2020, JIMD reports.

No effect of oral ketone ester supplementation on exercise capacity in patients with McArdle disease and healthy controls: A randomized placebo‐controlled cross‐over study

J. Vissing, N. Voermans, G. van Hall, 2022, Journal of inherited metabolic disease.

Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy

C. Krarup, F. Muntoni, P. Ruben, 2015, Brain : a journal of neurology.

Aerobic training in myotonia congenita: Effect on myotonia and fitness

G. Andersen, J. Vissing, N. Løkken, 2017, Muscle & nerve.

Prolonged fasting‐induced hyperketosis, hypoglycaemia and impaired fat oxidation in child and adult patients with spinal muscular atrophy type II

J. Vissing, G. van Hall, A. Born, 2021, Acta paediatrica.

No effect of triheptanoin in patients with phosphofructokinase deficiency

P. Laforêt, J. Vissing, G. van Hall, 2022, Neuromuscular Disorders.

European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders

N. Voermans, G. Tasca, H. Jungbluth, 2022, European journal of neurology.

Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA

J. Vissing, C. Thomsen, J. Dahlqvist, 2018, Neuromuscular Disorders.

MRI in sarcoglycanopathies: a large international cohort study

E. Bertini, E. Mercuri, F. Muntoni, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

POPDC3 Gene Variants Associate with a New Form of Limb Girdle Muscular Dystrophy

J. Vissing, M. Duno, P. Sarathchandra, 2019, Annals of neurology.

New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy.

G. Comi, B. Koritnik, K. Claeys, 2020, Brain : a journal of neurology.

Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

F. Rivier, C. Béroud, E. Malfatti, 2021, Journal of Neurology.

Muscle MRI in McArdle Disease

Miguel Ángel Martín, J. Vissing, F. Granata, 2022, Neurology.

No effect of resveratrol in patients with mitochondrial myopathy: A cross‐over randomized controlled trial

J. Vissing, M. Ørngreen, T. Krag, 2021, Journal of inherited metabolic disease.

Exercise Testing, Physical Training and Fatigue in Patients with Mitochondrial Myopathy Related to mtDNA Mutations

J. Vissing, K. Madsen, T. Jeppesen, 2021, Journal of clinical medicine.

Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I

J. Vissing, C. Thomsen, G. Hedermann, 2016, Annals of neurology.

Titrating a modified ketogenic diet for patients with McArdle disease: A pilot study

J. Vissing, R. Quinlivan, M. Ørngreen, 2020, Journal of inherited metabolic disease.

Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNA.

J. Vissing, J. Dahlqvist, G. Hedermann, 2017, Mitochondrion.

International patient group harnesses social media to help inform rare disease research: use of a low carbohydrate ketogenic diet in McArdle disease

N. Voermans, N. Løkken, Stacey L. Reason, 2021, Current opinion in endocrinology, diabetes, and obesity.

J. Vissing, M. Duno, A. Born, 2015, Muscle & nerve.

Patient-Reported Experiences with a Low-Carbohydrate Ketogenic Diet: An International Survey in Patients with McArdle Disease

A. Santalla, J. Vissing, N. Voermans, 2023, Nutrients.

G.P.117 Sodium valproate for McArdle disease (glycogen storage disease type V – GSDV)

J. Holton, R. Haller, J. Vissing, 2015, Neuromuscular Disorders.

No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency

J. Vissing, M. Ørngreen, T. Krag, 2020, Neuromuscular Disorders.

G.P.166 Muscle strength relative to cross-sectional area in hypertrophic calf muscles of patients affected by limb girdle type 2I and Becker muscular dystrophies

J. Vissing, C. Thomsen, G. Hedermann, 2015, Neuromuscular Disorders.

259th ENMC international workshop: Anaesthesia and neuromuscular disorders 11 December, 2020 and 28–29 May, 2021

N. Voermans, H. Jungbluth, S. Johannsen, 2021, Neuromuscular Disorders.

J. Vissing, M. Duno, A. Born, 2015, Muscle & nerve.

Fatigue and associated factors in 172 patients with McArdle disease: An international web-based survey

A. Santalla, N. Voermans, N. Løkken, 2023, Neuromuscular Disorders.

Results of an open label feasibility study of sodium valproate in people with McArdle disease

J. Holton, R. Haller, J. Vissing, 2020, Neuromuscular Disorders.